In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including ...

Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

These aren't for the faint of heart.

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Once again, OPNsense plugins come to my rescue ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

Nous Research has released Hermes Mixture of Agents 2.0 (MoA 2.0), an update to its open-source Hermes Agent framework that ...

Cathie Wood's ARK Invest purchased $41.2M in Tesla (TSLA) and $2.3M in Bullish while selling $25.3M in Roku shares. See full trade breakdown here.

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...